Malaysia vs Turkmenistan: Treatment success rate for patients treated for MDR-TB
Malaysia
71.0%
in 2022
Turkmenistan
71.0%
in 2022
Malaysia rank
91st
Turkmenistan rank
91st
Treatment success rate for patients treated for MDR-TB over time
- Malaysia
- Turkmenistan
How they compare
Malaysia currently reports 71.0% against 71.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2013 it was Malaysia ahead.
Malaysia ranks 91st and Turkmenistan ranks 91st of 163 countries.
Across the 2 decades both report, Malaysia averaged higher in 1 and Turkmenistan in 1.
Head to head by decade
| Decade | Malaysia | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.9% | 50.7% | 1.1% | Malaysia |
| 2020s | 64.0% | 67.3% | 3.3% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Malaysia or Turkmenistan?
- Malaysia, at 71.0% against 71.0% in Turkmenistan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Malaysia and Turkmenistan?
- 0.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Turkmenistan?
- 10 years are reported by both, from 2013 to 2022.
- How do Malaysia and Turkmenistan rank globally for treatment success rate for patients treated for mdr-tb?
- Malaysia ranks 91st and Turkmenistan ranks 91st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.